Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
![](/report_cover/2215/pap-smearhuman-papillomavirus-hpv-2017-2021-us-europe-japan_en.gif)
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 257 pages and 21 tables
I. INTRODUCTION
II. PAP SMEAR/HPV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra
12. Inverness DS2
13. J&J Vitros ECi/ECiQ
14. J&J Vitros 3600
15. J&J Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
Particle-Membrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
h. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
PCR
DAP-PCR
Immuno-PCR
QC-PCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA
3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
D. Personal Testing
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VIII. U.K.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
IX. U.S.A.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE PROFILES
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics/Theradiag
bioMerieux
Bio-Rad
CellSearch
Cepheid
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix/Clinical Genomics
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Life Technologies
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Vermillion
Wako Pure Chemicals
Wallac/PE
Zila
II. PAP SMEAR/HPV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra
12. Inverness DS2
13. J&J Vitros ECi/ECiQ
14. J&J Vitros 3600
15. J&J Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
Particle-Membrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
h. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
PCR
DAP-PCR
Immuno-PCR
QC-PCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA
3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
D. Personal Testing
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
VIII. U.K.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
IX. U.S.A.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT, SUPPLIER SALES AND MARKET SHARES
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE PROFILES
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics/Theradiag
bioMerieux
Bio-Rad
CellSearch
Cepheid
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix/Clinical Genomics
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Life Technologies
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Vermillion
Wako Pure Chemicals
Wallac/PE
Zila
LIST OF TABLES
Major Companies Developing or Marketing Pap Smear/HPV Tests
France PAP Smear Test Volume and Diagnostics Sales by Market Segment
France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
France PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Germany PAP Smear Test Volume and Diagnostics Sales by Market Segment
Germany Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Germany PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Italy PAP Smear Test Volume and Diagnostics Sales by Market Segment
Italy Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Italy PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Japan PAP Smear Test Volume and Diagnostics Sales by Market Segment
Japan Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Japan PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Spain PAP Smear Test Volume and Diagnostics Sales by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.K. PAP Smear Test Volume and Diagnostics Sales by Market Segment
U.K. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.S.A. Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Major Companies Developing or Marketing Pap Smear/HPV Tests
France PAP Smear Test Volume and Diagnostics Sales by Market Segment
France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
France PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Germany PAP Smear Test Volume and Diagnostics Sales by Market Segment
Germany Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Germany PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Italy PAP Smear Test Volume and Diagnostics Sales by Market Segment
Italy Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Italy PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Japan PAP Smear Test Volume and Diagnostics Sales by Market Segment
Japan Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Japan PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Spain PAP Smear Test Volume and Diagnostics Sales by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.K. PAP Smear Test Volume and Diagnostics Sales by Market Segment
U.K. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.S.A. Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers